STOCK TITAN

Dominari Holdings Provides Update on Share Repurchase Program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buyback
Rhea-AI Summary

Dominari Holdings Inc. (Nasdaq: DOMH) announced an update on its $2 million share repurchase program initiated on December 5, 2022. On January 23, 2023, the company repurchased 788 shares at $3.9114 per share. The company may continue repurchases depending on market conditions and regulatory limitations. Dominari has transitioned its focus to fintech and financial services, with plans to operate through its subsidiary, Dominari Financial Inc., while also developing therapeutics through Aikido Labs, LLC.

Positive
  • Initiation of a $2 million share repurchase program enhances shareholder value.
  • Recent share buyback demonstrates commitment to return capital to shareholders.
  • Transitioning to fintech and financial services may open new revenue streams.
Negative
  • None.

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on December 5, 2022.

The Company reported that on January 23, 2023, the Company purchased 788 shares of common stock at $3.9114 per share.

Additional shares may be repurchased from time to time in open market transactions, or other means in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 10b -18 of the Exchange Act. The timing, number of shares repurchased, and prices paid for the stock under this program will depend on general business and market conditions as well as corporate and regulatory limitations, including blackout period restrictions.

About Dominari Holdings Inc.

Dominari Holdings Inc. (f/k/a Aikido Pharma Inc.) until recently was focused primarily on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. In September 2022, the Company agreed to acquire a registered broker-dealer and transition its primary business operations to fintech and financial services.  Upon the final closing of this acquisition, the Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. The Company continues to develop its therapeutics and related patent technology, as well as other ventures, through its subsidiary, Aikido Labs, LLC. 

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:      

Hayden IR
Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

Dominari Holdings Inc. (f/k/a AIkido Pharma Inc):    

Phone: 212-745-1373
Email: investorrelations@aikidopharma.com
www.aikidopharma.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dominari-holdings-provides-update-on-share-repurchase-program-301728997.html

SOURCE Dominari Holdings Inc.

FAQ

What is the share repurchase program amount for Dominari Holdings (DOMH)?

Dominari Holdings has a share repurchase program amounting to $2 million.

How many shares did Dominari Holdings repurchase on January 23, 2023?

Dominari Holdings repurchased 788 shares on January 23, 2023.

At what price did Dominari Holdings repurchase its shares?

Dominari Holdings repurchased shares at a price of $3.9114 per share.

What is the purpose of the share repurchase program for DOMH?

The purpose of the share repurchase program is to enhance shareholder value.

What changes has Dominari Holdings made to its business focus?

Dominari Holdings has transitioned its focus to fintech and financial services.

DOMINARI HOLDINGS INC

NASDAQ:DOMH

DOMH Rankings

DOMH Latest News

DOMH Stock Data

84.79M
2.93M
45.24%
7.3%
0.24%
Biotechnology
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK